Cargando…
Drug screening of cancer cell lines and human primary tumors using droplet microfluidics
Precision Medicine in Oncology requires tailoring of therapeutic strategies to individual cancer patients. Due to the limited quantity of tumor samples, this proves to be difficult, especially for early stage cancer patients whose tumors are small. In this study, we exploited a 2.4 × 2.4 centimeters...
Autores principales: | Wong, Ada Hang-Heng, Li, Haoran, Jia, Yanwei, Mak, Pui-In, Martins, Rui Paulo da Silva, Liu, Yan, Vong, Chi Man, Wong, Hang Cheong, Wong, Pak Kin, Wang, Haitao, Sun, Heng, Deng, Chu-Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5567315/ https://www.ncbi.nlm.nih.gov/pubmed/28831060 http://dx.doi.org/10.1038/s41598-017-08831-z |
Ejemplares similares
-
Author Correction: Drug screening of cancer cell lines and human primary tumors using droplet microfluidics
por: Wong, Ada Hang-Heng, et al.
Publicado: (2019) -
Assessment of chimeric antigen receptor T cytotoxicity by droplet microfluidics in vitro
por: Wong, Kuan Un, et al.
Publicado: (2022) -
A digital microfluidic system with 3D microstructures for single-cell culture
por: Zhai, Jiao, et al.
Publicado: (2020) -
A digital microfluidic system for loop-mediated isothermal amplification and sequence specific pathogen detection
por: Wan, Liang, et al.
Publicado: (2017) -
Precision Medicine for Personalized Cancer Therapy
por: Wong, Ada Hang-Heng, et al.
Publicado: (2015)